Related Experiment Video
Updated: Jul 9, 2026

HPLC Measurement of the DNA Oxidation Biomarker, 8-oxo-7,8-dihydro-2’-deoxyguanosine, in Cultured Cells and Animal Tissues
Published on: August 1, 2015
Deoxyadenosine triphosphate as a mediator of deoxyguanosine toxicity in cultured T lymphoblasts
Abstract:
The mechanism by which 2'-deoxyguanosine is toxic for lymphoid cells is relevant both to the severe cellular immune defect of inherited purine nucleoside phosphorylase (PNP) deficiency and to attempts to exploit PNP inhibitors therapeutically. We have studied the cell cycle and biochemical effects of 2'-deoxyguanosine in human lymphoblasts using the PNP inhibitor 8-aminoguanosine. We show that cytostatic 2'-deoxyguanosine concentrations cause G1-phase arrest in PNP-inhibited T lymphoblasts, regardless of their hypoxanthine guanine phosphoribosyltransferase status. This effect is identical to that produced by 2'-deoxyadenosine in adenosine deaminase-inhibited T cells. 2'-Deoxyguanosine elevates both the 2'-deoxyguanosine-5'-triphosphate (dGTP) and 2'-deoxyadenosine-5'-triphosphate (dATP) pools; subsequently pyrimidine deoxyribonucleotide pools are depleted. The time course of these biochemical changes indicates that the onset of G1-phase arrest is related to increase of the dATP rather than the dGTP pool. When dGTP elevation is dissociated from dATP elevation by coincubation with 2'-deoxycytidine, dGTP does not by itself interrupt transit from the G1 to the S phase. It is proposed that dATP can mediate both 2'-deoxyguanosine and 2'-deoxyadenosine toxicity in T lymphoblasts.
Insights
2'-deoxyguanosine toxicity in T lymphoblasts is mediated by elevated dATP levels, causing G1-phase arrest. This finding is crucial for understanding purine nucleoside phosphorylase (PNP) deficiency and developing PNP inhibitors.
Area of Science:
- Biochemistry
- Cell Biology
- Immunology
Background:
- The toxicity of 2 -deoxyguanosine to lymphoid cells is relevant to purine nucleoside phosphorylase (PNP) deficiency and therapeutic strategies using PNP inhibitors.
- Understanding the precise mechanism of this toxicity is crucial for both inherited immune disorders and drug development.
Purpose of the Study:
- To investigate the cell cycle and biochemical effects of 2 -deoxyguanosine in human lymphoblasts using a PNP inhibitor.
- To elucidate the specific deoxyribonucleotide pools responsible for G1-phase arrest induced by 2 -deoxyguanosine.
Main Methods:
- Utilized human lymphoblasts and the PNP inhibitor 8-aminoguanosine to study 2 -deoxyguanosine effects.
- Analyzed cell cycle progression (G1-phase arrest) and intracellular deoxyribonucleotide pool dynamics (dGTP and dATP).
- Performed experiments with 2 -deoxycytidine to dissociate dGTP and dATP elevation.
Main Results:
- Cytostatic concentrations of 2 -deoxyguanosine induced G1-phase arrest in PNP-inhibited T lymphoblasts.
- 2 -Deoxyguanosine elevated both 2 -deoxyguanosine-5 -triphosphate (dGTP) and 2 -deoxyadenosine-5 -triphosphate (dATP) pools, leading to pyrimidine deoxyribonucleotide depletion.
- The onset of G1-phase arrest correlated with increased dATP levels, not dGTP levels.
- Elevated dGTP alone, without elevated dATP, did not halt cell cycle progression from G1 to S phase.
Conclusions:
- The G1-phase arrest induced by 2 -deoxyguanosine in T lymphoblasts is primarily mediated by elevated dATP pools.
- dATP appears to be the key mediator of both 2 -deoxyguanosine and 2 -deoxyadenosine toxicity in T lymphoblasts.
- These findings enhance the understanding of PNP deficiency pathogenesis and inform the design of therapies involving PNP inhibition.
More Related Videos
Related Concept Videos
GTPases and their Regulation
Large G-proteins, also known...
Desensitization and Tachyphylaxis
Several...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Drug Toxicity: Dose-Dependent Reactions
Biosynthesis of Nucleic Acids

